Clinical Trial Update: An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C [Phase 4]

View source ↗

Summary

An open-label Phase 4 study evaluated the safety and pharmacokinetics of nelfinavir in subjects with HIV infection and Hepatitis C. The trial aimed to character…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: Pfizer | Conditions: HIV Infection, Hepatitis C | Phase 4 | Status: COMPLETED